Relyea Zuckerberg Hanson LLC Sells 546 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Relyea Zuckerberg Hanson LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,592 shares of the healthcare conglomerate's stock after selling 546 shares during the period. Relyea Zuckerberg Hanson LLC's holdings in UnitedHealth Group were worth $2,323,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of UNH. CNB Bank raised its stake in shares of UnitedHealth Group by 3.7% during the 4th quarter. CNB Bank now owns 4,870 shares of the healthcare conglomerate's stock worth $2,464,000 after buying an additional 173 shares during the period. Saxon Interests Inc. increased its stake in shares of UnitedHealth Group by 49.4% in the 4th quarter. Saxon Interests Inc. now owns 3,437 shares of the healthcare conglomerate's stock worth $1,738,000 after acquiring an additional 1,136 shares during the last quarter. Avanza Fonder AB purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $40,861,000. Procyon Advisors LLC increased its position in shares of UnitedHealth Group by 13.3% during the 4th quarter. Procyon Advisors LLC now owns 23,701 shares of the healthcare conglomerate's stock worth $11,989,000 after purchasing an additional 2,780 shares during the last quarter. Finally, Border to Coast Pensions Partnership Ltd lifted its stake in UnitedHealth Group by 13.3% during the fourth quarter. Border to Coast Pensions Partnership Ltd now owns 160,002 shares of the healthcare conglomerate's stock worth $80,885,000 after purchasing an additional 18,737 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $0.56 during midday trading on Friday, reaching $510.03. 7,462,712 shares of the company's stock were exchanged, compared to its average volume of 5,104,531. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market capitalization of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company's 50 day simple moving average is $549.37 and its two-hundred day simple moving average is $562.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $5.83 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on UNH shares. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Finally, KeyCorp restated an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.